![]() Indian Express |
![]() Express India |
![]() Screen |
![]() Loksatta |
![]() Express Cricket |
![]() Kashmir Live |
![]() Biz Publications |





Mumbai, Oct 9: 2012. The country’s disease burden was around 37% higher than Brazil’s and 86% higher than China’s.
However, according to a recent Ernst & Young-Ficci study, healthcare insurance penetration in India is low, presenting a large opportunity for new entrants. Major health-related insurance schemes (ESIS, CGHS, group insurance, government schemes for the poor, community and voluntary insurance) cover only 12% of the Indian population. “Although private health insurance has grown at the rate of 40% per annum, low awareness, high premiums, and an inadequate and inefficient backend infrastructure has kept health insurance out of reach of a large part of the population,” the study adds.
There is a propensity to enhance health insurance coverage from 12% to 50% by 2015, E&Y says. In India, the share of private healthcare expenditure in total healthcare expenditure is 81%, while it is 56%, 61% and 38% for Brazil, China and Russia, respectively.
The cost of treatments, largely driven by private providers, has increased. Although price controls span 76 drugs covering 25% of the domestic pharmaceutical formulations market, the cost of drugs has risen at twice the wholesale price index. The share of diagnostics has been increasing and the cost of diagnostics & consumables form a significant portion of the treatment cost. ...
More from Frontpage
| Single Page Format | Previous - 1 - 2 |
![]() |
![]() |
![]() |


© 2009: The Indian Express Limited. All rights reserved throughout the world
